U.S. FDA approves biosimilar version of cancer drug Avastin
Thursday, 14 September 2017 (6 days ago)
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
TODAY’S TMJ4 - ▶ 01:09
GOBankingRates - ▶ 01:44
Recent related news
In 2016, Roche sold $3 billion worth of its blockbuster biotechnology drug Avastin. Last week, the Food and Drug Administration approved what’s expected to be...
18 hours ago • SFGate
FDA Indicates That Jaguar’s Canalevia Drug Product Candidate Qualifies as “Minor Use” for Exercise-Induced Diarrhea (EID) in Dogs, Rendering Canalevia Eligible for Conditional Approval for This Indication
SAN FRANCISCO--(BUSINESS WIRE)--Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing...
3 hours ago • Business Wire
This is a bull market, and some biotech stocks are the real raging bulls—especially when massive drug pipelines are at stake, and landmark FDA approvals shake...
1 week ago • OilPrice.com
Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)
STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, today...
1 week ago • Business Wire
Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.
Cycle Pharmaceuticals Ltd ("Cycle") is pleased to announce that it has received approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated...
1 day ago • FinanzNachrichten.de
Optinose Announces FDA Approval of XHANCE™ (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps
YARDLEY, Pa.--(BUSINESS WIRE)--Optinose, an ENT / Allergy specialty pharmaceutical company, announced today that the U.S. Food & Drug Administration (FDA)...
2 days ago • Business Wire